Live Breaking News & Updates on Gilmore Neil Oneill

Stay updated with breaking news from Gilmore neil oneill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Editas Medicine (NASDAQ:EDIT) Trading Up 14.2%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares were up 14.2% during trading on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at […] ....

Jessica Hopfield , Gilmore Neil Oneill , Morgan Stanley , Deutsche Bank , Swiss National Bank , Jpmorgan Chase Co , Editas Medicine Inc , Russell Investments Group Ltd , Securities Exchange Commission , Editas Medicine , Get Free Report , Neilo Neill , Exchange Commission , Director Jessica Hopfield , National Bank , Investments Group , Leber Congenital Amaurosis , Editas Medicine Daily ,

Editas Medicine (NASDAQ:EDIT) Trading Up 14.2%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares were up 14.2% during trading on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at […] ....

Jessica Hopfield , Gilmore Neil Oneill , Deutsche Bank , Morgan Stanley , Securities Exchange Commission , Russell Investments Group Ltd , Jpmorgan Chase Co , Swiss National Bank , Editas Medicine Inc , Editas Medicine , Get Free Report , Neilo Neill , Exchange Commission , Director Jessica Hopfield , National Bank , Investments Group , Leber Congenital Amaurosis , Editas Medicine Daily ,

Editas Medicine (NASDAQ:EDIT) Shares Up 14.2%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares rose 14.2% during trading on Wednesday . The stock traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares changed hands during trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at $5.43. Wall […] ....

Gilmore Neil Oneill , Jessica Hopfield , Jump Financial , Editas Medicine Inc , Swiss National Bank , Charles Schwab Investment Management Inc , Jpmorgan Chase Co , Principal Financial Group Inc , Securities Exchange Commission , Editas Medicine , Get Free Report , Neilo Neill , Director Jessica Hopfield , Exchange Commission , Financial Group , National Bank , Charles Schwab Investment Management , Schwab Investment Management , Leber Congenital Amaurosis , Editas Medicine Daily ,

Insider Selling: Editas Medicine, Inc. (NASDAQ:EDIT) CEO Sells 12,191 Shares of Stock

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) CEO Gilmore Neil O’neill sold 12,191 shares of the company’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $5.50, for a total value of $67,050.50. Following the sale, the chief executive officer now owns 315,279 shares of the […] ....

Gilmore Neil Oneill , Entrypoint Capital , Headlands Technologies , Jpmorgan Chase Co , Russell Investments Group Ltd , Editas Medicine Inc , Editas Medicine , Get Free Report , Neilo Neill , Medicine Stock Down , Street Markets , Investments Group , Leber Congenital Amaurosis , Editas Medicine Daily ,